Skip to main content
    • Wegovy tablets

    Wegovy Pill vs Rybelsus: What's the Difference?

    Wegovy pill vs Rybelsus: both are semaglutide tablets, but Rybelsus is for type 2 diabetes and Wegovy tablets for weight loss. Doses, licences and side effects.

    Jimah Alsaai MPharmJimah Alsaai MPharmSuperintendent Pharmacist
    GPhC 2232652
    Reviewed October 2026
    5 min read

    Short answer: Wegovy tablets and Rybelsus are both semaglutide tablets taken once a day, but they are licensed for different things. Rybelsus is licensed for adults with type 2 diabetes that is not well controlled, at 1.5mg, 4mg and 9mg; Wegovy tablets are licensed for weight management, at the same three steps and then a 25mg maintenance dose. Rybelsus is not licensed for weight loss, and the two are never taken together.

    Checked against the UK product information for both tablets on 18 October 2026.

    Are Wegovy tablets and Rybelsus the same?

    They contain the same medicine, semaglutide, and both are made with salcaprozate sodium, which helps semaglutide be absorbed in the stomach. Both are taken the same way: on an empty stomach after at least 8 hours without food, swallowed whole with a sip of water (up to 120ml), then a wait of at least 30 minutes before eating, drinking or taking other medicines. Where they differ is the strengths they come in and what they are licensed to treat.

    What is Rybelsus used for?

    • Licensed for adults with type 2 diabetes that is not well controlled, alongside diet and exercise, to help control blood glucose.
    • Doses: 1.5mg for the first month, then 4mg, and 9mg if needed. The UK product information gives 9mg as the highest recommended daily dose.
    • These tablets give the same amount of semaglutide as the earlier 3mg, 7mg and 14mg tablets, which the electronic medicines compendium now lists as discontinued.
    • Not licensed for weight management. Any weight change on Rybelsus is not the reason it is prescribed.

    What are Wegovy tablets used for?

    • Licensed for weight management in adults living with obesity (BMI 30 or more), or overweight (BMI 27 or more) with a weight-related condition, alongside a reduced-calorie diet and more physical activity.
    • Doses: 1.5mg, 4mg, 9mg and 25mg, with at least a month at each step. The 25mg dose is the maintenance dose, and if needed the dose can stay at the previous step.
    • The 25mg dose is the one studied in OASIS 4, the weight-loss trial the UK product information reports.

    Can you take Rybelsus for weight loss?

    Rybelsus stops at 9mg. Wegovy tablets share those same first three steps, 1.5mg, 4mg and 9mg, then continue to a 25mg maintenance dose. So the difference that matters is the 25mg step and what each product is licensed for. In OASIS 4, adults taking Wegovy tablets 25mg lost an average of 13.6% of their body weight over 64 weeks, against 2.2% on placebo, counting everyone who started treatment. Individual results vary, and Rybelsus does not reach that dose. Rybelsus is not licensed for weight management, so using it for weight loss would be outside its licence.

    This isn't a technicality. Using the product licensed for weight management means the dose, monitoring and information you're given all match what you're being treated for. If you're weighing up cost as part of the decision, see what Wegovy tablets cost per dose in the UK.

    What do Wegovy tablets and Rybelsus have in common?

    • The same active ingredient, semaglutide, as one tablet a day: never two tablets to make up a higher dose.
    • The same way of taking them: on an empty stomach after at least 8 hours without food, with a sip of water, and a 30-minute wait before eating, drinking or other medicines. See how to take the Wegovy pill.
    • Broadly the same side effects: stomach and gut symptoms such as nausea and diarrhoea are the most common, reported most often in the first months or while the dose is going up. More in Wegovy pill side effects.
    • With either, insulin or a sulphonylurea raises the risk of low blood sugar, so those doses may need lowering. The Rybelsus product information also asks for caution in people with diabetic retinopathy.
    • They are never taken together, or with any other GLP-1 medicine.

    For the dose steps in full, see the Wegovy tablets dosage schedule, and for how the tablets compare with the weekly injection, Wegovy pill vs injection.

    When to see your pharmacist or doctor

    Stop your treatment and seek urgent medical help if you experience: severe, persistent stomach pain, especially spreading to your back, with or without vomiting. This can be a sign of pancreatitis. Sudden pain in the upper right of your tummy, fever, or yellowing of the skin or eyes: possible gallbladder problems. Sudden loss of vision, or loss of part of your field of vision: seek same-day eye assessment. Swelling of the face or lips, difficulty breathing, or a widespread rash: call 999.

    Seek advice promptly if you notice: signs of dehydration during vomiting or diarrhoea (dizziness, reduced urination, dry mouth): keep sipping fluids, as dehydration can affect your kidneys; palpitations or a racing heartbeat at rest; a new neck lump, swelling, or hoarseness. If you have type 2 diabetes and use insulin or a sulfonylurea, know the signs of low blood sugar (sweating, shaking, sudden hunger, confusion) and treat promptly.

    Before any operation: tell your surgical or anaesthetic team you take a GLP-1 medicine. It slows stomach emptying, which matters for anaesthesia.

    Urgent help, genuine medicines and the official leaflets

    Frequently asked questions

    They contain the same medicine, semaglutide, as tablets taken once a day. They are different products with different licences: Rybelsus is for adults with type 2 diabetes that is not well controlled, and Wegovy tablets are for weight management.

    Rybelsus is not licensed for weight loss: its UK licence is for blood glucose control in type 2 diabetes, and its doses stop at 9mg. Wegovy tablets contain the same medicine and are licensed for weight management. Your pharmacist can talk you through whether they suit you.

    Both come as 1.5mg, 4mg and 9mg tablets. Rybelsus stops at 9mg, its highest licensed dose. Wegovy tablets go on to a 25mg maintenance dose, the dose studied in the OASIS 4 weight-loss trial.

    Yes. Wegovy tablets are licensed for weight management in adults with a BMI of 30 or more, or 27 or more with a weight-related condition, and you do not need to have diabetes. A pharmacist reviews every order before anything is supplied.

    Broadly, yes. For both, the most common side effects are stomach and gut symptoms such as nausea and diarrhoea, reported most often in the first months or while the dose is going up. With either, taking insulin or a sulphonylurea raises the risk of low blood sugar.

    No. Both are semaglutide, and the UK product information for Wegovy tablets says they should not be used with any other GLP-1 medicine. Tell your pharmacist about any diabetes medicine you take.

    The UK product information now lists Rybelsus as 1.5mg, 4mg and 9mg tablets and marks the 3mg, 7mg and 14mg tablets as discontinued. The newer tablets give the same amount of semaglutide as the older 3mg, 7mg and 14mg ones.

    Keep reading

    Ready to start?

    Start your free consultation with a GPhC-registered pharmacist.

    Begin consultation